Short-Acting Exenatide and Markers of Cardiovascular Disease in Type 1 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Trial

Nicklas J. Johansen, Thomas F. Dejgaard, Asger Lund, Camilla Schluntz, Emil List Larsen, Henrik E. Poulsen, Jens P. Gotze, Holger Moller, Tina Vilsboll, Henrik U. Andersen, Filip K. Knop

OriginalsprogEngelsk
Publikationsdatojun. 2020
DOI
StatusUdgivet - jun. 2020

Citationsformater